Integral Health Asset Management’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-243
| Closed | -$507K | – | 68 |
|
|
2022
Q1 | $507K | Sell |
243
-321
| -57% | -$670K | 0.13% | 70 |
|
|
2021
Q4 | $2.76M | Hold |
564
| – | – | 0.76% | 42 |
|
|
2021
Q3 | $3.54M | Buy |
564
+330
| +141% | +$2.07M | 1.02% | 41 |
|
|
2021
Q2 | $2.21M | Buy |
234
+26
| +13% | +$245K | 0.61% | 48 |
|
|
2021
Q1 | $1.81M | Buy |
+208
| New | +$1.81M | 0.52% | 54 |
|